DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Synchron - 2 Tom Oxley - 2 Oxley - 2 Neuralink - 2 Musk - 2 Sanjay Gupta’s - 1 Erin Burnett OutFront - 1 CNN — - 1
Top related locs:
U.S Neuralink UNESCO’s Pennsylvania Australia Acquandas
Top related orgs:
BCI - 3 SpaceX - 2 U.S . Food - 2 Drug Administration - 2 CNN - 1 US Food and Drug Administration - 1 Netflix - 1 US Securities and Exchange Commission - 1

Search resuls for: "Tom Oxley"


5 mentions found


☆ This ALS patient has a brain implant that translates his thoughts to computer commands
  + stars: | 2024-02-28 | by ( Catherine Thorbecke | Amanda Sealy | Nadia Kounang | ) edition.cnn.com   time to read: +14 min
Without ever clicking a mouse or touching a screen, Mark selected this command on his computer simply using signals from his brain. “I figured I had two choices: I could wallow in self-pity, or I could pick myself up by the bootstraps and do what I could to help,” Mark said. Synchron’s brain implant, the one Mark has, is called a Stentrode and consists of a stent with electrode sensors that can detect electrical brain activity. That external transmitter sits right above the internal transmitter and carries the signal from Mark’s brain to the computer almost instantaneously. Earlier this month, Musk also said Neuralink’s first human trial participant can control a computer mouse with their brain.
Persons: Sanjay Gupta’s, Erin Burnett OutFront, CNN —, Mark, Lou Gehrig’s, ” Mark, Elon Musk, ”, “, Sanjay Gupta, Synchron, Tom Oxley, hardwired, he’s, Mark didn’t, “ We’d, Maria Nardozzi, ” Oxley, CNN Mark, Musk’s Neuralink, Oxley, António Guterres, ” Elon Musk, Gonzalo Fuentes, Neuralink, Musk, Hope Organizations: CNN, BCI, US Food and Drug Administration, Netflix, US Securities and Exchange Commission, United Nations, Reuters, SpaceX Locations: Neuralink, UNESCO’s, Pennsylvania
☆ Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer
  + stars: | 2024-02-01 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +2 min
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. Synchron announced Thursday that it has acquired a minority equity stake in the German manufacturer Acquandas, which has the unique ability to layer the metals that make up one component of the company's implant. Founded in 2012, Synchron has developed a brain-computer interface, or a BCI, called the Synchron Switch. During initial studies, Synchron has so far implanted six patients in the U.S. and four patients in Australia. Synchron declined to share the specific size of Synchron's stake in Acquandas or the exact number of devices it is producing.
Persons: Philip O'Keefe, Synchron, Tom Oxley, Riki Banerjee, Oxley, Acquandas Organizations: BCI, U.S . Food, Drug Administration, CNBC Locations: U.S, Australia, Acquandas
☆ Elon Musk's Neuralink implants brain tech in human patient for the first time
  + stars: | 2024-01-29 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +2 min
The company is developing a brain implant that aims to help patients with severe paralysis control external technologies using only neural signals. The in-human clinical trial marks just one step on Neuralink's path toward commercialization. Neuralink did not disclose how many human patients will participate in its initial in-human trial. Paradromics is aiming to launch its first trial with human patients in the first half of this year. Precision Neuroscience carried out its first in-human clinical study last year.
Persons: Elon, Neuralink, Musk, Stephen Hawking, Blackrock Neurotech, Tom Oxley's Organizations: U.S . Food, Drug Administration, FDA, SpaceX, BCI, Neuroscience, Paradromics, Blackrock Locations: U.S
☆ Brain implant startup backed by Bezos and Gates is testing mind-controlled computing on humans
  + stars: | 2023-02-18 | by ( Ashley Capoot | ) www.cnbc.com   time to read: +7 min
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, using his BCI. Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. About 20 months earlier, O'Keefe was implanted with Synchron's BCI. Synchron's technology has caught the attention of its competitors. Source: SynchronIn January, the medical journal JAMA Neurology published the peer-reviewed, long-term safety results from a trial of Synchron's BCI system in Australia.
☆ These startups are beating Elon Musk in the race to let you mind meld with your computer
  + stars: | 2022-08-17 | by ( Adam Rogers | ) www.businessinsider.com   time to read: +21 min
That's when I started reporting on them, and like any good nerd I was compelled by what scientists could learn with these "brain computer interfaces." The race for implantable brain chips has been a long, deliberate marathon. Graham Felstead, who has severe paralysis, was the first person to have a BCI inserted via the blood vessels. Brain chips will enable them to perform simple actions on their own and reduce the need for round-the-clock care. "When we started in 2015 and I was pitching venture capitalists on brain computer interfaces, no one knew what a brain computer interface was," says Matt Angle, the CEO of Paradromics.
0 next >>
Total: 5